Latest filing published 26 Aug 2020 for XSpray Pharma AK, €60k.
Filing timeline
BuySaleInsider track record
Michael Wolff Jensen: trading record in brief
Michael Wolff Jensen discloses dealings in 2 companies, chiefly XSprayPharma AB and XSpray Pharma AK. We count 7 filings; the first trade dates from 2 October 2017 and the latest from 21 August 2020.
On the market, this insider has only sold: 3 sales, €42k in total.
The latest filing, published on 26 August 2020, reports a transaction of €60k in XSpray Pharma AK. Filings reach the Finansinspektionen feed a median of 1 day after the trade. Under the Market Abuse Regulation, managers have three business days to notify their trades. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Companies and markets linked to Michael Wolff Jensen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 25,000 shares@ SEK 25.00100.0% of flowAktieISIN SE0009973563FI:csv-f2fef741bea8ef799244
- 2,000 shares@ SEK 97.27544.1% of flowISIN SE0009973563FI:csv-c517bc7e8be3aef65b9b
- 832 shares@ SEK 60.8911.7% of flowISIN SE0009973563FI:csv-6ab4ced1d38288a4b2d4
- 3,168 shares@ SEK 60.3844.2% of flowISIN SE0009973563FI:csv-1f6a7700dac38dc543d5
- FörvärvISIN XSpray Pharma AB, Transfer of shares due to earn-out agreement with Karolinske Development ABFI:csv-d2deb477e545af023dcf
- FörvärvISIN XSpray Pharma AB, Transfer of shares due to earn-out agreement with KCIF Co-Investment Fund KommanditbolagFI:csv-0e7eeea90da865181263
- TeckningISIN XSprayPharma ABFI:csv-dbf2b99b4e13507a86d1
7 of 7 declarations